PLASMA ALDOSTERONE 519 MATERIALS AND METHODS
Several normal volunteers, 16 hospitalized primary aldosteronism, 8 uremic patients, 7 essential hypertensive patients, 11 congestive heart failure, 3 Cushing's disease, 2 Bartter's syndrome, 2 liver cirrhosis with ascites and 1 congenital adrenal hyperplasia were studied. a) Influence of postural change Plasma aldosterone of normal volunteers and patients suffering from miscellaneous diseases was measured in the morning at recumbency. The former was measured again after upright and walking during 2 hours and compared with the value of recumbency. All of these volunteers were not put on diet control during this experiment. b) Influence of furosemide Furosemide 100mg was intramuscularly injected in normal volunteers and patients with edema. Before and after injection, at the interval of 15min, the blood was drawn 6 times from cubital vein and aldosterone was measured. During these procedures, blood pressure, hematocrit, urine volume and urine electrolytes were measured. c) Influence of Angiotensin II Angiotensin II 10ng per Kg per minute in 250ml saline solution was intravenously drop infused during 1 hour in normal volunteers, primary aldosteronism and edematous patients. Plasma aldosterone was measured before and after procedure at the interval of 15min 6 times. At the same time, blood pressure, hematocrit and pulse rate were observed. d) Sodium restriction and loading Plasma aldosterone of primary aldosteronism was measured in the following conditions:
1) at the recumbency in early morning, 2) at the same condition after 3 days of sodium restricted diet (almost 3Gm of sodium chloride per day), 3) at the same condition after 3 days of sodium loaded diet (almost 20Gm of sodium chloride per day). e) Influence of Prostaglandin Prostaglandin A2 50 to 140ng per Kg per minute or Prostaglandin E1 100ng per Kg per minute was constantly infused to a hypertensive patient and normal dogs. REULTS a) Plasma aldosterone of normal volunteer and the patients suffering from miscellaneous diseases:
The result of Fig. 1 (left) shows plasma aldosterone of normal volunteer (recumbency or upright), primary aldosteronism, uremia (nephritis, malignant hypertension), essential hypertension, congestive heart failure , congenital adrenal hyperplasia and Bartter's syndrome. Normal range was distributed 0 to 28ng/100ml and the mean was 9.246.28 (S .D.) ng/100ml. In 8 of 16 cases of primary aldosteronism it was 50 to 244ng/100ml , and in other 8 cases it was 28 to 50ng/100ml. The mean was 70.3150.24 (S.D.)ng/100ml. The patients of renal disease with uremia showed the upper limit of normal range or slightly elevated value and its mean was 27.1513.89 (S.D.)ng/ 100ml. Seven cases of essential hypertension were within normal range and its mean was 10.558.51 (S.D.)ng/ 100ml.
One congenital adrenal hyperplasia was 66.1ng/100ml, 2 cases of Bartter's syndrome were 268 and 99ng/100ml respectively. Two patients of liver cirrhosis with ascites were as high as 38 and 107ng/100ml. Three Cushing disease were 10.5, 24.2 and 112.5ng/100ml. b) Influence of the postural change: Fig. 1 (right) shows plasma aldosterone of normal volunteer at recumbency and after walking for 2 hours in the morning. The mean value of 10 cases at recumbency was 7.313.28 (S.D.)ng/100ml.
The mean value after walking of 8 out of above 10 cases was 11.2518.96 (S.D.)ng/100ml. This was statistically significant. c) Influence of diuretica: Fig. 2 shows the plasma aldosterone before and after intramuscular injection of furosemide 100mg in one volunteer. Each sample was drawn at an interval of 30min. Hematocrit, urine electrolytes and volume were measured simultaneously. After the injection, urine volume and Na excretion were slightly increased. As K excretion was almost unchanged, Na/K ratio was increased. Before procedure, plasma aldosterone was 5.8ng/100ml. After that it was 12.9, 11.5, 22.3, 19.3, and 6.9ng/100ml respectively. This might mean that the dehydration and sodium diuresis increased the plasma aldosterone slightly. Same method was tried to the patients suffering from liver cirrhosis with ascites and congestive heart failure with edema ( Fig. 3 left and right). Both patients showed markedly increased sodium excretion and increased Na/K ratio and decreased urine osmotic pressure.
In patient with ascites, 2 samples drawn before procedure showed 101 and 103ng/100ml and after diuresis the values in 30min, 1, 2, 3, 4, 5, and 6 hours were 71.1, 67.9, 73.0, 68.1, 69.5, 69.5, and 58.8ng/100ml respectively. In patient of congestive heart failure, the values before procedure were 28.0 and 30.5ng/100ml and after 1, 2, 3, 4, and 6 hours of procedure, the values of plasma aldosterone were 10.3, 11.5, 6.0, 8.1, and 9.5ng/100ml respectively.
These results mean that the trend of plasma aldosterone in edematous patient exhibits a different behavior from normal volunteers. Nine and 24 hours after furosemide procedure, the aldosterone of an edematous patient markedly increased, such as 73 and 125ng/100ml, although it was riot pointed out in this figure. Such a phenomenon seems to show (Fig. 4, right) showed 10.3ng/100ml in pre-infusion and thereafter 16.4, 29.6, 34.4, 33.9, and 29.9ng/100ml respectively.
The increase of systolic and diastolic blood pressure were 26mmHg and 44mmHg in the former and 28mmHg and 20mmHg in the latter respectively. The former showed the slightly increased hematocrit, and the latter showed the decreased pulse rate. The same procedure was tried to the primary aldosteronism, who was confirmed to have had the adenoma of 16mm diameter by operation.
As shown in Fig. 5 (left) , the plasma aldosterone of pre-infusion was as high as 56.8ng/100ml.
At an interval of 15min after the start of constant infusion, the values of plasma aldosterone were 54.5, 43.2, 38.5, 30.9, and 30.3ng/100ml.
Systolic and diastolic blood pressure were increased 27mmHg and 15mmHg respectively. Fig 5 (right) shows the result in this patient obtained by the same procedure after 18 days of adrenalectomy. The plasma aldosterone before infusion was 2.0ng/100ml and after infusion it was 5.8, 5.0, 10.7, 24.1, and 8.7ng/100ml respectively. This shows the same reaction with normal persons. Fig. 6 shows the result in another case of primary aldosteronism who had an adenoma of 18mm diameter. The plasma aldosterone before procedure At an interval of 15min after that, the values were 38.5, 44.8, 36.9, and 33.4ng/100ml.
Hematocrit was decreased slightly from 40% to 38%. Systolic and diastolic blood pressure were increased 37mmHg and 20mmHg respectively. Fig. 7 (left) shows the result in nephrotic syndrome. Before procedure it was 32.2ng/100ml and after that the values were 54.1, 78.9, 78.8, 52.0, and 56.0ng/100ml.
Hematocrit was decreased markedly from 44.5% to 39%. Systolic and diastolic blood pressure were increased 43mmHg and 38mmHg respectively. Fig. 7 (right) shows the result of idiopathic edema. Before procedure it was 28.1ng/100ml, after the beginning of infusion 2 samples of 15 and 30min showed as high as 74.5 and 70.3ng/100ml, but in spite of continuation of infusion, the values were gradually decreased to 27.3 and 21.7ng/100ml and after the stop it became 13.7ng/100ml. Fig . 8 shows the summary of these results which is displayed as the value subtracted from before procedure. This figure shows that the edematous patients are more sensitive to Angiotensin II as compared with normal control and primary aldosteronism is less sensitive. e) Influence of sodium restriction and loading: Six patients of primary aldosteronism were examined. Plasma at recumbency was drawn before procedure, after sodium chloride 3Gm/day and 20Gm/day during 3 days. The plasma aldosterone of these 3 points was measured. In spite of adenoma, 2 of 6 cases showed the marked response to the sodium restriction and loading (Fig. 9) . The values of each case were 54.4, 133.6, 112.0ng/100ml and 105.5, 145.0, 78.5ng/ 100ml respectively. Other 4 cases of primary aldosteronism, however, made no response to sodium restriction and loading. Two cases of normal persons who were shown by broken line showed the normal fluctuation.
f) Influence of Prostaglandin A2 or E1: Fig. 10 shows the influence of Prostaglandin A2 to the patient with malignant hypertension. Prostaglandin A2 50ng per Kg per minute was Fig. 9 . The change of plasma aldosterone level by low salt diet (sodium chloride 3Gm/day) for 3 days and high salt diet (sodium chloride 20Gm/day) for 3 days. infused during 1 hour continuously. Blood pressure was gradually decreased and the excretion of urinary sodium was slightly increased. Despite no change of plasma cortisol, the plasma aldosterone was gradually increased. The values were 30.0, 26.1, 60.5, 89.1, 149.3, and 67.8ng/100ml respectively. Fig. 11 (left) is an example which was tried to a dog. Before using of Prostaglandin A2 120ng per Kg per minute, saline solution 500ml was infused. The values of each spot were 8. 4, 5.2, 3.4, 5.5, 5.7, 16.3, 14.9, 15.0, 17.8, 18 .2, 13.9, and 12.6ng/100ml respectively. The increased urinary volume and sodium excretion will be due to the sodium diuresis. The decreased plasma aldosterone will be also due to volume expansion. Prostaglandin A2 120ng
per Kg per minute in saline solution 500ml, however, increased the plasma aldosterone. Fig. 11 (right) shows the various types of effect to plasma aldosterone, when Prostaglandin A2 or E1 was infused, but it seems that the effect was not so strong as in Angiotensin II infusion.
DISCUION
Recently by the development of radioimmunoassay method, the measurement of plasma aldosterone became easy and rapid. Although the measurement of urine aldosterone excretion and secretion rate so far in use gave us many useful information, it was impossible to observe the plasma aldosterone level in short time interval. This paper showed not only the plasma aldosterone in various diseases but also the sequential change of it in various stimulation. At recumbency in morning of normal volunteer without diet control, all values were less than 10ng/100ml, the values of plasma aldosterone in primary aldosteronism were scattered widely.
The maximum was 244ng/100ml and minimum was 28ng/100ml which was near the upper value of normal range. These results were almost same with the data of Fukuchi1) and Brown.2) From these results it will be said that the upper limit of normal range can not always deny the primary aldosteronism.
In fact, the plasma aldosterone in a primary aldosteronism showed the day-to-day variations. Although chronic nephritis with uremia showed the upper limit of normal control, some cases of malignant hypertension showed high value. All of essential hypertension were normal value, but congestive heart failure with edema was relatively high value. Congenital adrenal hyperplasia, Bartter's syndrome and liver cirrhosis with edema showed markedly high value. Gowenlock (1959) 3) reported the urinary aldosterone excretion due to postural change. The plasma aldosterone due to postural change is found in the paper of Wolff and Torbica (1963) .4) Michalakis and Horton reported the relation between plasma renin and aldosterone in postural change.
Sympathicotonia caused by upright stimulates the afferent arteriole of glomeruli which induces the increased renin secretion. This increased renin accelerates the aldosterone secretion through the Angiotensin II. Upright from recumbency decreases the hepatic blood flow, consequently the plasma aldosterone increases. In all cases of control the plasma aldosterone after 2 hours of upright and walking more or less increased.
Many papers describing about the relation between edema and aldosterone are found. Luetscher (1954)5) found that nephrotic patient excreted urine containing much aldosterone, thereafter this was watched as the substance causing edema.
It is now recognized, however, that 1) the congestive heart failure in stable equilibrium of hemodynamic condition does not always show the high urinary aldosterone excretion,2) the patient of primary aldosteronism who is excreting much aldosterone in urine does not always show edema,3) by the administration of a large amount of aldosterone during 1 or 2 weeks, so-called escaped phenomenon appears. This escaped phenomenon, however, does not appear in congestive heart failure.6) Such a fact comes into problem when discussing about the role of aldosterone in edema.
In the above-mentioned results, the plasma aldosterone of normal control increased by diuresis. This fact will be explained by the feed-back mechanism due to sodium diuresis.
On the other hand, that of patients with edema was immediately decreased by diuresis. This fact may mean that the improvement of regulatory mechanism of water and electrolytes decreased the plasma aldosterone. Even in such patient, however, the plasma aldosterone was markedly increased after disappearing of diuretic effect as described before. Such a phenomenon cannot be explained only from the improvement of homeostasis. It looks like the body has set about to strive again for the restoration of lost sodium and water.
In normal control Angiotensin II stimulates the secretion of aldosterone as already known.7) Aldosterone secretion in nephrotic syndrome showed the higher sensitivity to Angiotensin II infusion than normal control.
In primary aldosteronism the plasma aldosterone was decreased by Angiotensin II infusion unexpectedly. Ganong (1966)8) said that the long time suppressed plasma renin activity decreased the reactivity of aldosterone stimulation to Angiotensin II, on the other hand, the increased plasma renin activity Jap. Heart J. November, 1973 increased it.
Response of plasma aldosterone to low or high sodium intake was seen in 2 cases of primary aldosteronism with adenoma. This suggests the participation of auto-regulatory system in some cases of primary aldosteronism.
Recently Fichman and Horton (1972)9 reported that Prostaglandin A1 increased the plasma aldosterone significantly. His result agrees with this paper. In over a half of his cases the increased plasma aldosterone was unaccompanied by the increased plasma cortisol or plasma renin activity. From these results he concluded that Prostaglandin may either have a direct physiological role in the regulation of aldosterone secretion or may influence aldosterone indirectly consequent to Prostaglandin induced natriuresis.
